2024 Q2 Form 10-Q Financial Statement

#000162828024021198 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $348.0K $2.738M $372.0K
YoY Change -87.69% 636.02%
Cost Of Revenue $11.75M $11.13M $0.00
YoY Change
Gross Profit -$11.40M -$8.388M $372.0K
YoY Change -503.25% -2354.84%
Gross Profit Margin -3275.86% -306.36% 100.0%
Selling, General & Admin $8.889M $7.560M $7.139M
YoY Change 17.21% 5.9% -23.15%
% of Gross Profit 1919.09%
Research & Development $2.836M $3.546M $17.73M
YoY Change -85.42% -80.0% 37.48%
% of Gross Profit 4766.67%
Depreciation & Amortization $1.200M $1.219M $1.077M
YoY Change 20.0% 13.18% 449.49%
% of Gross Profit 289.52%
Operating Expenses $11.73M $11.11M $24.87M
YoY Change -56.63% -55.35% 12.09%
Operating Profit -$23.13M -$19.49M -$24.50M
YoY Change -4.47% -20.43% 10.42%
Interest Expense $1.052M $1.252M
YoY Change -13.77% 4217.24%
% of Operating Profit
Other Income/Expense, Net $1.185M $1.184M $2.598M
YoY Change -7.28% -54.43% -84.23%
Pretax Income -$21.90M
YoY Change 283.62%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$21.94M -$18.31M -$21.90M
YoY Change -4.31% -16.4% 283.62%
Net Earnings / Revenue -6304.6% -668.74% -5887.37%
Basic Earnings Per Share -$0.12 -$0.10 -$0.14
Diluted Earnings Per Share -$0.12 -$0.10 -$0.14
COMMON SHARES
Basic Shares Outstanding 174.9M shares 174.9M shares 154.3M shares
Diluted Shares Outstanding 175.8M shares 174.5M shares 154.1M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $119.0M
YoY Change -43.95%
Cash & Equivalents $36.74M $36.33M $87.81M
Short-Term Investments $31.20M
Other Short-Term Assets $5.365M
YoY Change -3.73%
Inventory $4.425M $3.161M
Prepaid Expenses
Receivables $981.0K $1.039M $689.0K
Other Receivables $0.00
Total Short-Term Assets $84.66M $98.25M $125.1M
YoY Change -19.69% -21.44% -43.37%
LONG-TERM ASSETS
Property, Plant & Equipment $17.76M $16.93M $18.37M
YoY Change -3.92% -7.86% 82.71%
Goodwill
YoY Change
Intangibles $4.790M $4.857M
YoY Change
Long-Term Investments
YoY Change
Other Assets $785.0K $816.0K $239.0K
YoY Change 582.61% 241.42% -8.43%
Total Long-Term Assets $26.47M $25.39M $22.39M
YoY Change 18.51% 13.39% 52.81%
TOTAL ASSETS
Total Short-Term Assets $84.66M $98.25M $125.1M
Total Long-Term Assets $26.47M $25.39M $22.39M
Total Assets $111.1M $123.6M $147.5M
YoY Change -13.01% -16.15% -37.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.833M $2.910M $2.699M
YoY Change 105.53% 7.82% 54.67%
Accrued Expenses $12.57M
YoY Change 90.54%
Deferred Revenue $5.700M $5.600M $5.929M
YoY Change 78.13% -5.55% -13.56%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.522M
YoY Change -16.24%
Total Short-Term Liabilities $26.00M $19.89M $23.02M
YoY Change 14.53% -13.61% 25.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $80.00K
YoY Change -20.79%
Total Long-Term Liabilities $80.00K
YoY Change -94.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.00M $19.89M $23.02M
Total Long-Term Liabilities $80.00K
Total Liabilities $42.09M $35.81M $30.22M
YoY Change 38.2% 18.53% -16.15%
SHAREHOLDERS EQUITY
Retained Earnings -$736.4M -$714.5M -$640.5M
YoY Change 11.0% 11.55% 17.24%
Common Stock $18.00K $18.00K $16.00K
YoY Change 12.5% 12.5% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $69.04M $87.82M $117.2M
YoY Change
Total Liabilities & Shareholders Equity $111.1M $123.6M $147.5M
YoY Change -13.01% -16.15% -37.38%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$21.94M -$18.31M -$21.90M
YoY Change -4.31% -16.4% 283.62%
Depreciation, Depletion And Amortization $1.200M $1.219M $1.077M
YoY Change 20.0% 13.18% 449.49%
Cash From Operating Activities -$18.91M -$18.51M
YoY Change 2.16% -4.46%
INVESTING ACTIVITIES
Capital Expenditures $953.0K $2.610M
YoY Change -63.49% -35.41%
Acquisitions
YoY Change
Other Investing Activities $74.67M
YoY Change
Cash From Investing Activities $34.69M $72.06M
YoY Change -51.86% -1883.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$81.00K -$303.0K
YoY Change -73.27% -90.66%
NET CHANGE
Cash From Operating Activities -$18.91M -$18.51M
Cash From Investing Activities $34.69M $72.06M
Cash From Financing Activities -$81.00K -$303.0K
Net Change In Cash $15.70M $53.25M
YoY Change -70.51% -299.73%
FREE CASH FLOW
Cash From Operating Activities -$18.91M -$18.51M
Capital Expenditures $953.0K $2.610M
Free Cash Flow -$19.86M -$21.12M
YoY Change -5.95% -9.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Government Assistance Current Statement Of Financial Position Extensible Enumeration
GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2738000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
372000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
11126000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
-8388000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
372000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3546000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17732000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2034000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1852000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5526000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5287000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
11106000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
24871000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-19494000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-24499000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1239000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1252000 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-688000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-55000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
658000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1184000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2598000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18310000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-18310000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21901000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21901000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174514538 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174514538 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154123911 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154123911 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
136974000 usd
CY2023Q1 ghw Stock Issued During Period Value Stock Compensation Plan
StockIssuedDuringPeriodValueStockCompensationPlan
104000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2059000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-81000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-303000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21901000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
117236000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
103357000 usd
CY2024Q1 ghw Stock Issued During Period Value Stock Compensation Plan
StockIssuedDuringPeriodValueStockCompensationPlan
-81000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2854000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-18310000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
87820000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-18310000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21901000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1219000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1077000 usd
CY2024Q1 ghw Non Cash Interest Income
NonCashInterestIncome
-995000 usd
CY2023Q1 ghw Non Cash Interest Income
NonCashInterestIncome
-762000 usd
CY2024Q1 ghw Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
326000 usd
CY2023Q1 ghw Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
299000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2854000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2059000 usd
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
-1979000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-688000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-29000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
48000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1309000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4330000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1145000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
266000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1731000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
153000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-529000 usd
CY2024Q1 ghw Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-4024000 usd
CY2023Q1 ghw Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-4657000 usd
CY2024Q1 ghw Increase Decrease In Product Warranty Accrual
IncreaseDecreaseInProductWarrantyAccrual
1193000 usd
CY2023Q1 ghw Increase Decrease In Product Warranty Accrual
IncreaseDecreaseInProductWarrantyAccrual
1231000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1184000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-306000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-380000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-346000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18910000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18510000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
953000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2610000 usd
CY2024Q1 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-35645000 usd
CY2023Q1 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-74668000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
34692000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
72058000 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
400000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
104000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
81000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15701000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
53245000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22483000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36655000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38184000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89900000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
449000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
413000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
517000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
623000 usd
CY2024Q1 ghw Transfers Between Inventory And Property And Equipment Net
TransfersBetweenInventoryAndPropertyAndEquipmentNet
1051000 usd
CY2023Q1 ghw Transfers Between Inventory And Property And Equipment Net
TransfersBetweenInventoryAndPropertyAndEquipmentNet
0 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36332000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87811000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
906000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1413000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
946000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
676000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38184000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89900000 usd
CY2024Q1 ghw Battery Flexible Energy Capacity Minimum
BatteryFlexibleEnergyCapacityMinimum
4 h
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Certain immaterial prior year amounts have been reclassified to conform with current year presentation. These reclassifications had no effect on the reported results of operations.</span></div>
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
6778000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7740000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2284000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1236000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3403000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5685000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
12465000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
14661000 usd
CY2024Q1 us-gaap Inventory Adjustments
InventoryAdjustments
9304000 usd
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
11295000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
3161000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3366000 usd
CY2024Q1 us-gaap Inventory Adjustments
InventoryAdjustments
9300000 usd
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
11300000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27363000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25547000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10435000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9281000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16928000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16266000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
1200000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1100000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
67000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2676000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5681000 usd
CY2024Q1 ghw Materials And Related Purchases Current
MaterialsAndRelatedPurchasesCurrent
1910000 usd
CY2023Q4 ghw Materials And Related Purchases Current
MaterialsAndRelatedPurchasesCurrent
2083000 usd
CY2024Q1 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
910000 usd
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
802000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
0 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
545000 usd
CY2024Q1 ghw Accrued Capital Expenditures
AccruedCapitalExpenditures
52000 usd
CY2023Q4 ghw Accrued Capital Expenditures
AccruedCapitalExpenditures
327000 usd
CY2024Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
650000 usd
CY2023Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
637000 usd
CY2024Q1 ghw Other Accrued Liability And Other Liabilities Current
OtherAccruedLiabilityAndOtherLiabilitiesCurrent
354000 usd
CY2023Q4 ghw Other Accrued Liability And Other Liabilities Current
OtherAccruedLiabilityAndOtherLiabilitiesCurrent
680000 usd
CY2024Q1 ghw Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
6552000 usd
CY2023Q4 ghw Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
10755000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
12500 shares
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2129000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1643000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2583000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1504000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1083000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
273000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-307000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
0 usd
CY2024Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3322000 usd
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2874000 usd
CY2024Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
75000 usd
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
29151075 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
29151075 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
29151075 shares
CY2024Q1 ghw Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0 shares
CY2024Q1 ghw Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
0 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
29151075 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11473727 shares
CY2023Q1 ghw Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0 shares
CY2023Q1 ghw Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
0 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11473727 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
12500 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2854000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2059000 usd
CY2024Q1 ghw Share Based Compensation Arrangement By Share Based Payment Awards Potential Increase In Shares Authorized Percentage Of Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardsPotentialIncreaseInSharesAuthorizedPercentageOfSharesOutstanding
0.05
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2598382 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.33
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1422000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9900 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.54
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2588482 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.34
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
648000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1775256 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.10
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y7M13D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1198000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1881196 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.14
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y4M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
584000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
30300000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y21D
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2738000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
372000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
149000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
253000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
19955000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20781000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
104000 usd
CY2024Q1 ghw Contract With Customer Liability Period Increase Decrease
ContractWithCustomerLiabilityPeriodIncreaseDecrease
800000 usd
CY2024Q1 ghw Contract With Customer Liability Advance Payment
ContractWithCustomerLiabilityAdvancePayment
100000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5600000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
14400000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18310000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18310000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21901000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21901000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174514538 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174514538 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154123911 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154123911 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
52122554 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26285501 shares
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-021198-index-headers.html Edgar Link pending
0001628280-24-021198-index.html Edgar Link pending
0001628280-24-021198.txt Edgar Link pending
0001628280-24-021198-xbrl.zip Edgar Link pending
exhibit311-ceocertq12024.htm Edgar Link pending
exhibit312-cfocertq12024.htm Edgar Link pending
exhibit321-ceocertq12024.htm Edgar Link pending
exhibit322-cfocertq12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ghw-20240331.htm Edgar Link pending
ghw-20240331.xsd Edgar Link pending
ghw-20240331_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
ghw-20240331_cal.xml Edgar Link unprocessable
ghw-20240331_def.xml Edgar Link unprocessable
ghw-20240331_lab.xml Edgar Link unprocessable
ghw-20240331_pre.xml Edgar Link unprocessable
ghw-20240331_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable